Pay in 4 interest-free payments of $5.18 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
COVID-19 and vitamin-D NICE
In August 2024, Eli Lilly & Company announced the positive outcomes of the SURMOUNT-1 trial, indicating that Tirzepatide (marketed as Zepbound and Mounjaro) decreased the risk of developing type 2 diabetes by 94% in individuals with prediabetes, obesity, or overweight
Rybka J, Kupczyk D, Kdziora-Kornatowska K, Motyl J, Czuczejko J, Szewczyk-Golec K
HuaLDengJWangZWangYChenBMaYet al
US$ 20.55
US$ 29.22
US$ 23.14
US$ 22.85
US$ 25.02
